These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 30529635)
1. Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors. Teske KA; Dash RC; Morel SR; Chau LQ; Wechsler-Reya RJ; Hadden MK Eur J Med Chem; 2019 Feb; 163():320-332. PubMed ID: 30529635 [TBL] [Abstract][Full Text] [Related]
2. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma. Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493 [TBL] [Abstract][Full Text] [Related]
3. Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles. Liu M; Liang G; Zheng H; Zheng N; Ge H; Liu W Life Sci; 2019 Jan; 217():222-228. PubMed ID: 30543826 [TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors. Pace JR; Teske KA; Chau LQ; Dash RC; Zaino AM; Wechsler-Reya RJ; Hadden MK J Med Chem; 2019 Apr; 62(8):3873-3885. PubMed ID: 30896941 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of hedgehog signaling by stereochemically defined des-triazole itraconazole analogues. Wen J; Teske KA; Kyle Hadden M Bioorg Med Chem Lett; 2020 Jan; 30(2):126794. PubMed ID: 31761657 [TBL] [Abstract][Full Text] [Related]
6. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo. Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258 [TBL] [Abstract][Full Text] [Related]
7. Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinoma. Wen J; Hadden MK Eur J Med Chem; 2022 Jan; 228():114005. PubMed ID: 34844141 [TBL] [Abstract][Full Text] [Related]
8. A molecular dynamics approach to identify an oxysterol-based hedgehog pathway inhibitor. Dash RC; Maschinot CR; Hadden MK Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):168-177. PubMed ID: 27825830 [TBL] [Abstract][Full Text] [Related]
9. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913 [TBL] [Abstract][Full Text] [Related]
10. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Kim J; Tang JY; Gong R; Kim J; Lee JJ; Clemons KV; Chong CR; Chang KS; Fereshteh M; Gardner D; Reya T; Liu JO; Epstein EH; Stevens DA; Beachy PA Cancer Cell; 2010 Apr; 17(4):388-99. PubMed ID: 20385363 [TBL] [Abstract][Full Text] [Related]
11. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance. Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107 [TBL] [Abstract][Full Text] [Related]
12. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance. Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling. Maschinot CA; Chau LQ; Wechsler-Reya RJ; Hadden MK Eur J Med Chem; 2019 Jan; 162():495-506. PubMed ID: 30471551 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of vitamin D3 analogues with C-11 modifications as inhibitors of Hedgehog signaling. Maschinot CA; Hadden MK Bioorg Med Chem Lett; 2017 Sep; 27(17):4011-4014. PubMed ID: 28780161 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies. Galperin I; Dempwolff L; Diederich WE; Lauth M J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059 [TBL] [Abstract][Full Text] [Related]
16. Design and biological evaluation of phenyl imidazole analogs as hedgehog signaling pathway inhibitors. Sun C; Zhang Y; Wang H; Yin Z; Wu L; Huang Y; Zhang W; Wang Y; Hu Q Chem Biol Drug Des; 2021 Mar; 97(3):546-552. PubMed ID: 32946174 [TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationship Studies of Vitamin D3 Analogues Containing an Ether or Thioether Linker as Hedgehog Pathway Inhibitors. Wen J; Hadden MK ChemMedChem; 2018 Apr; 13(7):748-753. PubMed ID: 29409113 [TBL] [Abstract][Full Text] [Related]
18. Design of Hedgehog pathway inhibitors for cancer treatment. Bariwal J; Kumar V; Dong Y; Mahato RI Med Res Rev; 2019 May; 39(3):1137-1204. PubMed ID: 30484872 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway. Büttner A; Seifert K; Cottin T; Sarli V; Tzagkaroulaki L; Scholz S; Giannis A Bioorg Med Chem; 2009 Jul; 17(14):4943-54. PubMed ID: 19541490 [TBL] [Abstract][Full Text] [Related]
20. Hedgehog Signaling: From Basic Biology to Cancer Therapy. Wu F; Zhang Y; Sun B; McMahon AP; Wang Y Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]